Home
About SinovacProductsPipelineInvestorsContact Us
 
 
  SITEMAP 中文版
  Investors
IR Home
President Message
Corporate Governance
Social Responsibility
Press Releases
Media Report
SEC Filings
Analyst Coverage
FAQs
Home Page
 
FAQs

What is Sinovac's ticker symbol and on what exchange does it trade?
Sinovac Biotech, Ltd. trades on the American Stock Exchange under the ticker symbol "SVA"
 
Where is Sinovac headquartered?
Sinovac's principal executive offices are located at:
No. 39 Shangdi Xi Road,
Haidian District, Beijing 100085
People’s Republic of China
 
When and where was the Company incorporated?
Sinovac Biotech, Ltd. was incorporated on March 1, 1999 in Antigua and Barbuda
 
When does Sinovac's fiscal year end?
Sinovac operates on a December 31 fiscal year end.
Who is Sinovac's independent auditor?
The Company's independent auditor is Ernst and Young.
 
Who is on Sinovac's Board of Directors?
To view a complete Board list with biographies, click on the Board of Directors link in the Investors section of the Company's Web site.
 
Does Sinovac currently pay a dividend on its common stock?
Sinovac does not currently pay a dividend on its common stock.
Does Sinovac offer a direct stock purchase plan?
The Company does not currently offer a direct stock purchase plan.
 
How can I find information on Sinovac’s SEC filings?
Sinovac files periodic reports with the SEC, including:
·        Annual Report on Form 20-F
·        Semi-Annual Reports on Form 6-K
 
Theses filings can be obtained from the SEC Filings link on the Investors section of the Company Web site or by visiting www.sec.gov.
What is Sinovac's CUSIP number?
The Company's CUSIP number is P8696W104.
 
How can I be placed on the Sinovac's e-mail news distribution list?
To be placed on the Company's e-mail news distribution list, please visit the Contact Us link on the Company Web site.
 
What indices is Sinovac listed in?
Sinovac is listed in the Halter USX China Index, AMEX Composite Index, and the AMEX Healthcare Sub Index.
 
How can I obtain additional financial or investor information on Sinovac?
Current or potential investors that wish to obtain more information about Sinovac Services should visit the Contact Us link on the Company’s Web site.
 
Who handles investor relations for Sinovac?
The Ruth Group is Sinovac’s investor relations agency of record. For additional investor information, please refer back to the Investors page of the Company’s Web site.
How do I access Sinovac’s financial results?
Sinovac reports its financial results on a semi-annual basis and files them on Form 20-F or Form 6-K with the SEC. 

 
 
Copyright © 2009 Sinovac Biotech Ltd. All rights reserved.